Employer and Workplace Drug Testing Market Onsite Testing Adoption Rat

The global employer and workplace drug testing market was valued at USD 6,105.1 million in 2024 and is projected to reach USD 9,089.9 million by 2033, growing at a CAGR of 4.6% from 2025 to 2033. This market centers on detecting illicit drugs and controlled substances in biological samples to support workplace safety, regulatory compliance, and employee productivity.

Drug testing methods—including urine, oral fluid, hair, and blood analysis—are widely used across industries such as transportation, manufacturing, construction, and energy to reduce workplace accidents, mitigate risks, and minimize absenteeism. Employer and workplace drug testing serves critical functions including pre-employment screening, random testing, and post-incident investigations, helping organizations maintain safe, compliant, and productive work environments.

Market growth is driven by increasingly strict government regulations, corporate adoption of drug-free workplace policies, and advancements in rapid testing kits and laboratory-based confirmation tools. Rising awareness of the impact of substance abuse on employee performance, safety, and operational costs is further propelling adoption across both developed and emerging economies.

Key Market Trends & Insights

• North America dominated the global market with 48.99% revenue share in 2024.
• The U.S. remained the leading market within North America in 2024.
• By type, post-employment testing led with 77.8% revenue share in 2024.
• By product, consumables accounted for the largest share at 33.1% in 2024.
• By mode, urine testing held the largest share at 40.9% in 2024.
• By drug, cannabis/marijuana dominated with 58.3% revenue share in 2024.
• By end use, the other professional services segment led with 38.3% revenue share in 2024.

Download a free sample PDF of the Employer and Workplace Drug Testing Market Intelligence Study by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 6,105.1 Million
• 2033 Projected Market Size: USD 9,089.9 Million
• CAGR (2025–2033): 4.6%
• Largest Market in 2024: North America

Competitive Landscape

Key players in the employer and workplace drug testing market are prioritizing the development of innovative testing solutions and the acquisition of industry certifications to expand their capabilities. Strategic initiatives—including partnerships, mergers & acquisitions, and technology collaborations—are increasingly being adopted to strengthen market presence, broaden regional reach, and improve access to rapid, accurate, and non-invasive drug testing technologies for diverse work environments.

Prominent Companies

• First Advantage
• Laboratory Corporation of America Holdings (Labcorp)
• Drägerwerk AG & Co. KGaA
• Bio-Rad Laboratories, Inc.
• Abbott
• Clinical Reference Laboratory Inc.
• Quest Diagnostics
• Cordant Health Solutions
• DISA Global Solutions
• HireRight, LLC

Recent Developments

• March 2025 – Premier Biotech completed the acquisition of OraSure Technologies’ substance abuse testing business and the Mexican subsidiary of Green Earth Biomedical LLC, strengthening its capabilities in oral fluid drug testing and expanding its workplace testing portfolio.
• May 2024 – Omega Laboratories partnered with Cannabix Technologies Inc. to integrate Cannabix’s THC breathalyzer technology into its testing services, becoming the exclusive provider of laboratory support and enhancing accuracy and efficiency in cannabis detection.
• April 2024 – Accurate Background launched its next-generation drug and health screening services, integrating advanced technology and enhanced data analytics to deliver faster results, improved accuracy, and more comprehensive insights into employee health and substance use.

Explore Horizon Databook – the world’s most comprehensive market intelligence platform by Grand View Research.

Conclusion

The employer and workplace drug testing market is experiencing steady growth fueled by regulatory pressures, rising safety concerns, and advancements in testing technology. As organizations continue prioritizing compliance, risk mitigation, and employee well-being, demand for efficient, accurate, and scalable drug testing solutions is expected to remain strong across all major industries and regions.